Company: CSTL
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001447362-25-000097
Chunk: 5

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-08-04
Form: 10-Q
Item: Item 1
Chunk 5
---
47)Proceeds from lease incentives received190 — Proceeds from issuance of term debt— 10,000 Net cash (used in) provided by financing activities(1,452)10,686 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.6

Table of ContentsCASTLE BIOSCIENCES, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)(UNAUDITED)(in thousands)

 Six Months EndedJune 30, 20252024NET CHANGE IN CASH AND CASH EQUIVALENTS(37,476)(13,269)Beginning of period119,709 98,841 End of period$82,233 $85,572 DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:Asset acquisition, liability for contingent consideration$2,500 $— Accrued purchases of property and equipment$6,822 $2,148 Operating lease assets obtained in exchange for lease obligations$4,687 $— Decrease in operating lease assets with corresponding change in lease liabilities$(104)$(7)Finance lease assets obtained in exchange for lease obligations$119 $166 Property and equipment acquired with tenant improvement allowance$7,224 $— 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.7

Table of ContentsCASTLE BIOSCIENCES, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(UNAUDITED) 

1. Organization and Description of Business

Castle Biosciences, Inc. (the ‘‘Company,” “we,” “us” or “our”) was incorporated in the state of Delaware on September 12, 2007. We are a commercial-stage diagnostics company focused on providing clinicians and their patients with personalized, clinically actionable information to inform treatment decisions and improve health outcomes. We are based in Friendswood, Texas (a suburb of Houston, Texas) and our laboratory operations are conducted at our facilities located in Phoenix, Arizona and Pittsburgh, Pennsylvania.

2. Summary of Significant Accounting Policies

Basis of PresentationOur unaudited condensed consolidated financial statements include the accounts of Castle Biosciences, Inc. and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States of America (‘‘U.S. GAAP’’). All intercompany accounts and transactions have been eliminated